BLFS
Biolife Solutions Inc

2,931
Mkt Cap
$1.17B
Volume
1.04M
52W High
$29.62
52W Low
$19.10
PE Ratio
-352.26
BLFS Fundamentals
Price
$24.20
Prev Close
$22.48
Open
$23.50
50D MA
$23.91
Beta
1.56
Avg. Volume
305,080.55
EPS (Annual)
-$0.3124
P/B
3.28
Rev/Employee
$620,735.48
$1,083.66
Loading...
Loading...
News
all
press releases
BioLife Solutions (NASDAQ:BLFS) Raised to Buy at Wall Street Zen
Wall Street Zen upgraded BioLife Solutions from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
BioLife Solutions (NASDAQ:BLFS) Shares Gap Up - What's Next?
BioLife Solutions (NASDAQ:BLFS) Shares Gap Up - What's Next...
MarketBeat·2d ago
News Placeholder
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
BioLife Solutions (BLFS) delivered earnings and revenue surprises of +300.00% and +5.16%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
BioLife Solutions (NASDAQ:BLFS) Posts Quarterly Earnings Results, Beats Estimates By $0.24 EPS
BioLife Solutions (NASDAQ:BLFS - Get Free Report) announced its earnings results on Thursday. The medical equipment provider reported $0.22 EPS for the quarter, beating analysts' consensus estimates...
MarketBeat·3d ago
News Placeholder
BioLife Solutions Q4 Earnings Call Highlights
BioLife Solutions (NASDAQ:BLFS) reported fourth-quarter and full-year 2025 results highlighting double-digit growth, expanding profitability, and a more focused portfolio following recent divestiture...
MarketBeat·3d ago
News Placeholder
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing...
PR Newswire·3d ago
News Placeholder
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the five analysts that are covering the company, MarketBeat reports. One...
MarketBeat·8d ago
News Placeholder
BioLife Solutions (BLFS) Projected to Post Quarterly Earnings on Thursday
BioLife Solutions (NASDAQ:BLFS) will be releasing its Q4 2025 earnings after the market closes on Thursday, February 26. (View Earnings Report at...
MarketBeat·10d ago
News Placeholder
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026 BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial...
PR Newswire·12d ago
News Placeholder
BioLife Solutions (NASDAQ:BLFS) Stock Price Passes Below Two Hundred Day Moving Average - Time to Sell?
BioLife Solutions (NASDAQ:BLFS) Stock Crosses Below 200-Day Moving Average - Here's What Happened...
MarketBeat·16d ago
<
1
2
...
>

Latest BLFS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.